Neues zu klinischen Aspekten und der Pathophysiologie chronischer Kopfschmerzen

Zusammenfassung

Chronische Kopfschmerzen, insbesondere chronische Migräne, chronischer Kopfschmerz vom Spannungstyp und Kopfschmerz bei Medikamentenübergebrauch, stellen ein zunehmendes Gesundheitsproblem in unserer Gesellschaft dar. Risikofaktoren für die Entstehung sind v. a. die missbräuchliche Einnahme von Schmerzmitteln, Triptanen und Ergotaminen. Daneben begünstigen auch die hohe Frequenz des primären episodischen Kopfschmerzes, psychiatrische Komorbiditäten wie Depressionen und Angststörungen, niedriger sozialer Status, Adipositas aber auch die Einnahme von Koffein ihr Auftreten. Die genauen pathophysiologischen Entstehungsmechanismen chronischer Kopfschmerzen liegen dabei noch größtenteils im Dunkeln. Erste Erklärungsansätze beinhalten genetische Mutationen, Modifikation der trigeminalen Schmerzverarbeitung, pharmakologische sowie funktionelle und strukturelle zerebrale Veränderungen. Auch ein erhöhter Liquordruck wird als mögliche kausale Ursache chronischer Kopfschmerzen diskutiert. Dieser Artikel will die bisher bekannten pathophysiologischen Mechanismen chronischer Kopfschmerzerkrankungen beleuchten und für die weitere Therapie hoffnungsvolle Behandlungsansätze aufzeigen.

Abstract

Chronic headache, especially chronic migraine, chronic tension-type headache and medication-overuse headache, is a growing health problem in our society. Risk factors for its development are mainly abusive intake of analgesics, triptans and ergotamines. Additionally, the high frequency of the primary headache, psychiatric comorbidities such as depression and anxiety disorder, low socioeconomic status, obesity as well as caffeine intake all promote the occurrence of chronic headache. The detailed pathophysiological mechanisms that lead to the development of chronic headache are still unresolved. Initial approaches for explanation favour genetic mutations, modification of the trigeminal nociceptive system, pharmacological as well as functional and structural cerebral changes. Moreover, an increased liquor pressure is also discussed as a probable cause of chronic headache. This article illustrates the known pathophysiological mechanisms of chronic headache and tries to identify promising approaches for new therapies.

Schlüsselwörter

chronische Kopfschmerzen - Pathophysiologie - Medikamentenübergebrauch - Liquordruck

Keywords

chronic headache - pathophysiology - medication overuse - liquor pressure

Literatur

• 1 Headache Classification Subcommittee of the International Headache Society . The international classification of headache disorders 2nd ed.  Cephalalgia. 2004;  24 8-152
• 2 Limmroth V, Katsarav Z, Fritsche G. et al . Features of medication overuse headache following overuse of different acute headache drugs.  Neurology. 2002;  59 1011-1014
• 3 Wang S J, Fuh J L, Lu S R. et al . Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up.  Neurology. 2000;  54 314-319
• 4 Scher A I, Stewart W F, Liberman J. et al . Prevalence of frequent headache in a population sample.  Headache. 1998;  38 497-506
• 5 Castillo J, Munoz P, Guitera V. et al . Epidemiology of chronic daily headache in the general population.  Headache. 1999;  39 190-196
• 6 Lu S R, Fuh J L, Chen W T. et al . Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors.  Cephalalgia. 2001;  21 980-986
• 7 Prencipe M, Casini A R, Ferretti C. et al . Prevalence of headache in an elderly population: attack frequency, disability, and use of medication.  J Neurol Neurosurg Psychiatry. 2001;  70 377-381
• 8 Lantéri-Minet M, Auray J P, El Hasnaoui A. et al . Prevalence and description of chronic daily headache in the general population in France.  Pain. 2003;  102 143-149
• 9 Colás R, Muñoz P, Temprano R. et al . Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life.  Neurology. 2004;  62 1338-1342
• 10 Granella F, Farina S, Malferrari G. et al . Drug abuse in chronic headache: a clinico-epidemiologic study.  Cephalalgia. 1987;  7 15-19
• 11 Micieli G, Manzoni G C, Granella F. et al . Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M, eds Drug-induced headache. New York; Springer 1988: 20-28
• 12 Robinson R G. Pain relief for headaches. Is self-medication a problem?.  Can Fam Physician. 1993;  39 867-868, 871–872
• 13 Rapoport A, Stang P, Gutterman D L. et al . Analgesic rebound headache in clinical practice: data from a physician survey.  Headache. 1996;  36 14-19
• 14 Silberstein S D, Lipton R B. Chronic daily headache.  Curr Opin Neurol. 2000;  13 277-283
• 15 Scher A I, Stewart W F, Ricci J A. et al . Factors associated with the onset and remission of chronic daily headache in a population-based study.  Pain. 2003;  106 81-89
• 16 Katsarava Z, Schneeweiss S, Kurth T. et al . Incidence and predictors for chronicity of headache in patients with episodic migraine.  Neurology. 2004;  62 788-790
• 17 Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headaches de novo?.  Headache. 1988;  28 61-62
• 18 Bahra A, Walsh M, Menon S. et al . Does chronic daily headache arise de novo in association with regular use of analgesics?.  Headache. 2003;  43 179-190
• 19 Zwart J A, Dyb G, Hagen K. et al . Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study.  Neurology. 2003;  61 160-164
• 20 Katsarava Z, Muessig M, Dzagnidze A. et al . Medication overuse headache: rates and predictors for relapse in a 4-year prospective study.  Cephalalgia. 2005;  25 12-15
• 21 Wiendels N J, Knuistingh Neven A, Rosendaal F R. et al . Chronic frequent headache in the general population: prevalence and associated factors.  Cephalalgia. 2006;  26 1434-1442
• 22 Kavuk I, Weimar C, Kim B T. et al . One-year prevalence and socio-cultural aspects of chronic headache in Turkish immigrants and German natives.  Cephalalgia. 2006;  26 1177-1181
• 23 Bigal M E, Liberman J N, Lipton R B. Obesity and migraine: a population study.  Neurology. 2006;  66 545-550
• 24 Scher A I, Stewart W F, Lipton R B. Caffeine as a risk factor for chronic daily headache: a population-based study.  Pain. 2003;  106 81-89
• 25 Atasoy H T, Atasoy N, Unal A E. et al . Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache.  Eur J Pain. 2005;  9 285-291
• 26 Park J W, Kim J S, Kim Y I. et al . Serotonergic activity contributes to analgesic overuse in chronic tension-type headache.  Headache. 2005;  45 1229-1235
• 27 Di Lorenzo C, Sances G, Di Lorenzo G. et al . The wolframin His611Arg polymorphism influences medication overuse headache.  Neurosci Lett. 2007;  424 179-184
• 28 Schmidt-Wilcke T, Leinisch E, Straube A. et al . Gray matter decrease in patients with chronic tension type headache.  Neurology. 2005;  65 1483-1486
• 29 Welch K M, Nagesh V, Aurora S K. et al . Periaqueductal gray matter dysfunction in migraine: cause or burden of the illness?.  Headache. 2001;  41 629-637
• 30 Afridi S, Goadsby P J. New onset migraine with a brain stem cavernous angioma.  J Neurol Neurosurg Psychiatry. 2003;  74 680-682
• 31 Obermann M, Gizewski E R, Limmroth V. et al . Symptomatic migraine and pontine vascular malformation: evidence for a key role of the brainstem in the pathophysiology of chronic migraine.  Cephalalgia. 2006;  26 763-766
• 32 Raskin N H, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain.  Headache. 1987;  27 416-420
• 33 Veloso F, Kumar K, Toth C. Headache secondary to deep brain implantation.  Headache. 1998;  38 507-515
• 34 Fumal A, Laureys S, Di Clemente L. et al . Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine.  Brain. 2006;  129 543-550
• 35 Diener H C, Dichgans J, Scholz E. et al . Analgesic-induced chronic headache: long-term results of withdrawal therapy.  J Neurol. 1989;  236 9-14
• 36 Pini L A, Cicero A F, Sandrini M. Long-term follow up of patients for chronic headache with analgesic overuse.  Cephalalgia. 2001;  21 878-883
• 37 Suhr B, Evers S, Bauer B. et al . Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy.  Cephalalgia. 1999;  19 44-49
• 38 Volkow N D, Fowler J S, Wolf A P. et al . Changes in brain glucose metabolism in cocaine dependence and withdrawal.  Am J Psychiatry. 1991;  148 621-626
• 39 Volkow N D, Fowler J S, Wang G J. The addicted human brain viewed in the lighht of imaging studies: brain circuits and treatment strategies.  Neuropharmacology. 2004;  47 3-13
• 40 London E D, Ernst M, Graant S. et al . Orbitofrontal cortex and human drug abuse: functional imaging.  Cerebral Cortex. 2000;  10 334-342
• 41 Matharu M S, Bartsch T, Ward N. et al . Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study.  Brain. 2004;  127 220-230
• 42 Afridi S K, Matharu M S, Lee L. et al . A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate.  Brain. 2005;  128 932-939
• 43 Denuelle M, Fabre N, Payoux P. et al . Hypothalamic activation in spontaneous migraine attacks.  Headache. 2007;  47 1418-1426
• 44 Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache.  Arch Neurol. 1996;  53 373-376
• 45 de Tommaso M, Valeriani M, Guido M. et al . Abnormal brain processing of cutaneous pain in patients with chronic migraine.  Pain. 2003;  101 25-32
• 46 Ayzenberg I, Obermann M, Nyhuis P. et al . Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures.  Cephalalgia. 2006;  26 1106-1114
• 47 Aurora S K, Barrodale P M, Tipton R L. et al . Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies.  Headache. 2007;  47 996-1003
• 48 Reuter U, Salomone S, Ickenstein G W. et al . Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats.  Cephalalgia. 2004;  24 398-407
• 49 Dobson C F, Tohyama Y, Diksic M. et al . Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain.  Cephalalgia. 2004;  24 2-11
• 50 Srikiatkhachorn A, Tarasub N, Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache.  Headache. 2000;  40 343-350
• 51 Srikiatkhachorn A, Anthony M. Serotonin receptor adaptation in patients with analgesic-induced headache.  Cephalalgia. 1996;  16 419-422
• 52 Griffiths R R, Woodson P P. Caffeine physical dependence: a review of human and laboratory animal studies.  Psychopharmacology. 1988;  94 437-451
• 53 Griffiths R R, Woddson P P. Reinforcing properties of caffeine: studies in humans and laboratory animals.  Pharmacol Biochem Behav. 1988;  29 419-427
• 54 van Dusseldorp M, Katan M B. Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial.  BMJ. 1990;  300 1558-1559
• 55 Silverman K, Evans S M, Strain E C. et al . Withdrawal syndrome after the double-blind cessation of caffeine consumption.  N Engl J Med. 1992;  327 1109-1114
• 56 Ziegler D K. Opiate and opioid use in patients with refractory headache.  Cephalalgia. 1994;  14 5-10
• 57 Fisher M A, Glass S. Butorphanol (Stadol): a study in problems of current drug information and control.  Neurology. 1997;  48 1156-1160
• 58 Saper J R, Jones J M. Ergotamine tartrate dependency: features and possible mechanisms.  Clin Neuropharmacol. 1986;  9 244-256
• 59 Huff A L, Hupp S L, Rothrock J F. Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension.  Cephalalgia. 1996;  16 451-452
• 60 Mathew N T, Ravishankar K, Sanin L C. Coexistence of migraine and idiopathic intracranial hypertension without papilledema.  Neurology. 1996;  46 1226-1230
• 61 Wang S J, Silberstein S D, Patterson S. et al . Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center.  Neurology. 1998;  51 245-249
• 62 Evans R W, Silberstein S D. Diagnostic testing for chronic daily headache.  Headache. 2002;  42 556-559
• 63 Bono F, Messina D, Giliberto C. et al . Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache.  J Neurol. 2008;  255 807-812
• 64 Bono F, Messina D, Giliberto C. et al . Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine.  Neurology. 2006;  67 419-423
• 65 Donnet A, Metellus P, Levrier O. et al . Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients.  Neurology. 2008;  70 641-647
• 66 Higgins J N, Cousins C, Owler B K. et al . Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting.  J Neurol Neurosurg Psychiatry. 2003;  74 1662-1666